Antibiotics Lecture 04

42
Bio 319: Antibiotics Lecture Four Topic Inhibitors of Nucleic acid synthesis Inhibitors of synthesis of essential metabolites Introduction to antibiotics resistance Lecturer: Dr. G. Kattam Maiyoh 03/21/13 GKM/BIO319:Antibiotics/Sem2/2013 1

description

mechanisms of action

Transcript of Antibiotics Lecture 04

Page 1: Antibiotics Lecture 04

Bio 319: Antibiotics

Lecture Four

TopicInhibitors of Nucleic acid synthesisInhibitors of synthesis of essential metabolitesIntroduction to antibiotics resistance

Lecturer: Dr. G. Kattam Maiyoh

03/21/13 GKM/BIO319:Antibiotics/Sem2/2013 1

Page 2: Antibiotics Lecture 04

Reminder

03/21/13 2GKM/BIO319:Antibiotics/Sem2/2013

Page 3: Antibiotics Lecture 04

The Action of Antimicrobial Drugs

03/21/13 3GKM/BIO319:Antibiotics/Sem2/2013

Page 4: Antibiotics Lecture 04

Inhibitors of Cell Wall Synthesis

03/21/13 4GKM/BIO319:Antibiotics/Sem2/2013

Page 5: Antibiotics Lecture 04

Protein synthesis inhibitors– Aminoglycosides

– Tetracyclins

- Spectinomycin

– Macrolides

– Chloramphenicol

– Clindamycin

03/21/13 GKM/BIO319:Antibiotics/Sem2/2013 5

Page 6: Antibiotics Lecture 04

Inhibitors of Nucleic Acid Synthesis

~Inhibitors of DNA synthesis~Inhibitors of RNA synthesis

03/21/13 6GKM/BIO319:Antibiotics/Sem2/2013

Page 7: Antibiotics Lecture 04

Inhibitors of RNA SynthesisFor this class of antibiotics, selectivity is due to differences between prokaryotic and eukaryotic RNA polymerase i.e.

All RNA polymerases are multi-protein complexes, however, the number of proteins that are assembled to form the active enzyme is much larger in eukaryotes;

•The basic catalytic core is made up of 12 subunits.

•By comparison, bacterial RNAP has 5 subunits.

03/21/13 7GKM/BIO319:Antibiotics/Sem2/2013

Page 8: Antibiotics Lecture 04

Rifampin, Rifamycin, Rifampicin, Rifabutin (bactericidal)

• Mode of action - These antimicrobials bind to DNA-dependent RNA polymerase and inhibit initiation of mRNA synthesis.

• Spectrum of activity - Broad spectrum but is used most commonly in the treatment of tuberculosis

• Resistance – Common– For example; – Resistance to rifampicin develops quickly during treatment, so

monotherapy should not be used to treat these infections — it should be used in combination with other antibiotics.

– Resistance to rifampicin arises from mutations that alter residues of the rifampicin binding site on RNA polymerase, resulting in decreased affinity for rifampicin.

• Combination therapy - Since resistance is common, rifampin is usually used in combination therapy.

03/21/13 8GKM/BIO319:Antibiotics/Sem2/2013

Page 9: Antibiotics Lecture 04

Inhibitors of DNA SynthesisFor this class of antibiotics, selectivity due to differences between prokaryotic and eukaryotic DNA replication enzymes

Consider the following:

Eukaryotic replication is more complicated. •First, they have multiple ori per chromosome that allow for bidirectional synthesis of the linear chromosome. •They also use several DNA polymerases (I, II, III), and ligase (seals the nicks in the DNA strand), and RNA primer (gives a 3' end for the DNA polymerase to start synthesis).

•As for other differences in their synthesis of DNA is their speed, prokaryotes can replicate their chromosome at about 1,000 bp/sec, while eukaryotes can replicate their chromosomes at about 100 bp/sec. •They also differ in the number of ori, eukaryotes (as it was stated above) has multiple ori, while prokaryotes have only one.

03/21/13 9GKM/BIO319:Antibiotics/Sem2/2013

Page 10: Antibiotics Lecture 04

The Quinolones

• Current drugs are fluoridated 4-quinolones

• Broad coverage (some broader than others)

• Targets DNA gyrase (G-) and topoisomerase IV (G+)

• Resistance due to efflux and mutations in targets

03/21/13 10GKM/BIO319:Antibiotics/Sem2/2013

Page 11: Antibiotics Lecture 04

Pharmacological attributes of Quinolones• Favorable pharmacological attributes

– Orally administered, quickly absorbed, even with a full stomach

– Excellent bioavailability in a wide range of tissues and body fluids (including inside cells)

• Mostly cleared by the kidneys– Exceptions are pefloxacin and

moxifloxacin which are metabolized by liver

• Ciprofloxacin, ofloxacin, and pefloxacin are excreted in breast milk

““Got Cipro?”Got Cipro?”

03/21/13 11GKM/BIO319:Antibiotics/Sem2/2013

Page 12: Antibiotics Lecture 04

Therapeutic Uses of Quinolones

• Urinary tract infections

• Prostatitis• STD’s– Chlamydia– Chancroid - painful

sores on the genitalia– Not syphilis or

gonorrhea (due to increased resistance)

03/21/13 12GKM/BIO319:Antibiotics/Sem2/2013

Page 13: Antibiotics Lecture 04

Therapeutic Uses of Quinolones

• GI and abdominal – Travelers diarrhea– Shigellosis– Typhoid fever

• Respiratory tract– New agents for strep. pneumonia

03/21/13 13GKM/BIO319:Antibiotics/Sem2/2013

Page 14: Antibiotics Lecture 04

Therapeutic Uses of Quinolones

• Bone, joint, soft tissue– Ideal for chronic

osteomylitis - infection of the bone or bone marrow• Resistance developing in

S. aureus, P. aeruginosa, and S. marcesens

– Good against polymicrobial infections like diabetic foot ulcers

03/21/13 14GKM/BIO319:Antibiotics/Sem2/2013

Page 15: Antibiotics Lecture 04

Therapeutic Uses of Quinolones

• Ciprofloxacin for anthrax and tuleremia (rabbit fever, deer fly fever, Ohara's fever)

• Combined with other drugs, useful for atypical Mycobacterium sp.

Pulmonary AnthraxPulmonary Anthrax

03/21/13 15GKM/BIO319:Antibiotics/Sem2/2013

Page 16: Antibiotics Lecture 04

Toxicity/Contraindications of Quinolones• Nausea, vomiting, abdominal discomfort (common)• Diarrhea and antibiotic-associated colitis (uncommon to rare)• CNS side effects

– Mild headache and dizziness (common to rare)– Hallucinations, delirium, and seizures (rare)

• Arthropy in immature animals (common)– Quinolones not given to children unless benefits outweigh the risks

• Leukopenia, eosinophila, heart arythmias (rare)

delirium - disorder involving incoherent speech, hallucinations, etc., caused by intoxication, fever, etc

03/21/13 16GKM/BIO319:Antibiotics/Sem2/2013

Page 17: Antibiotics Lecture 04

Antimetabolite Antimicrobials

03/21/13 17GKM/BIO319:Antibiotics/Sem2/2013

Page 18: Antibiotics Lecture 04

Inhibitors of Folic Acid Synthesis

• Basis of Selectivity• Review of Folic

Acid Metabolism

p-aminobenzoic acid + Pteridine

Dihydropteroic acid

Dihydrofolic acid

Tetrahydrofolic acid

Pteridine synthetase

Dihydrofolate synthetase

Dihydrofolate reductase

ThymidinePurines

Methionine

Trimethoprim

Sulfonamides

03/21/13 18GKM/BIO319:Antibiotics/Sem2/2013

Page 19: Antibiotics Lecture 04

Sulfonamides, Sulfones (bacteriostatic)

• Mode of action - These antimicrobials are analogues of para-aminobenzoic acid and competitively inhibit formation of dihydropteroic acid.

• Spectrum of activity - Broad range activity against gram-positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections.

• Resistance - Common

• Combination therapy - The sulfonamides are used in combination with trimethoprim; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains.

03/21/13 19GKM/BIO319:Antibiotics/Sem2/2013

Page 20: Antibiotics Lecture 04

Trimethoprim, Methotrexate, Pyrimethamine (bacteriostatic)

• Mode of action - These antimicrobials binds to dihydrofolate reductase and inhibit formation of tetrahydrofolic acid.

• Spectrum of activity - Broad range activity against gram-positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections.

• Resistance - Common

• Combination therapy - These antimicrobials are used in combination with the sulfonamides; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains.

03/21/13 20GKM/BIO319:Antibiotics/Sem2/2013

Page 21: Antibiotics Lecture 04

Sulfonamides

• Analogues of para-aminobenzoic acid

• Broad spectrum• Competitive inhibitors of

dihydropteroate synthase – needed for folic acid synthesis

Gerhard Domagk gets a Nobel Gerhard Domagk gets a Nobel for Medicine, 1939.for Medicine, 1939.

03/21/13 21GKM/BIO319:Antibiotics/Sem2/2013

Page 22: Antibiotics Lecture 04

Sulfonamides• Mostly absorbed from GI tract• Binds variably to serum albumin • Wide tissue distribution, including

transplacentally• Variably inactivated in liver by

acetylation and then excreted in urine

• Some agents can precipitate in acid urine

03/21/13 22GKM/BIO319:Antibiotics/Sem2/2013

Page 23: Antibiotics Lecture 04

1. Rapidly Absorbed and Eliminated Sulfonamides

• Sulfisoxazole, sulfamethoxazole, sulfadiazine

• Bind extensively to plasma proteins

• Highly concentrated in urine (cidal)

• Sulfamethoxazole combined with trimethoprim (Bactrim) is widely used to treat a variety of infections (esp. UTI)

03/21/13 23GKM/BIO319:Antibiotics/Sem2/2013

Page 24: Antibiotics Lecture 04

2. Poorly Absorbed Sulfonamides

• E.g. Sulfasalazine• Poorly absorbed in GI tract• Used to treat ulcerative colitis

and irritable bowel syndrome• Gut flora metabolize drug into

2 compounds, 1 toxic- sulfapyridine, 1 therapeutic (5-aminosalicylate)

• Hence is a prodrug – effective after breakdown

Ulcerative Colitis

03/21/13 24GKM/BIO319:Antibiotics/Sem2/2013

Page 25: Antibiotics Lecture 04

Sulfonamides for Topical Use

• E.g. 1.Sulfacetamide– Good penetration in eye

– Non-irritating

• 2. Silver sulfadiazine– Prevention and treatment of

burn wound infections

Bacterial corneal infectionBacterial corneal infection

03/21/13 25GKM/BIO319:Antibiotics/Sem2/2013

Page 26: Antibiotics Lecture 04

Long Acting Sulfonamide

• Serum half-life is measured in days rather than minutes or hours

• E.g. Sulfadoxine

• Combined with pyirethamine to treat malaria

Plasmodium vivaxPlasmodium vivax

03/21/13 26GKM/BIO319:Antibiotics/Sem2/2013

Page 27: Antibiotics Lecture 04

Therapeutic Uses of Sulfonamides

• Urinary tract infections• Nocardiosis -serious infection

caused by a fungus-like bacterium that begins in the lungs and can spread to the brain.

• Toxoplasmosis - caused by protozoan (avoid using in pregnant women)

Nocardia asteroidesNocardia asteroides

03/21/13 27GKM/BIO319:Antibiotics/Sem2/2013

Page 28: Antibiotics Lecture 04

Toxicity/Contraindications of Sulfonamides - UT

• Crystallization in acid urine– Common to uncommon

depending on drug.

– Alkalize urine or increase hydration

03/21/13 28GKM/BIO319:Antibiotics/Sem2/2013

Page 29: Antibiotics Lecture 04

Toxicity/Contraindications of Sulfonamides - blood

• Acute hemolytic anemia – Rare to extremely rare

– Associated with glucose-6-phosphate dehydrogenase activity in RBC

• Agranulocytosis - failure of the bone marrow to make enough white

blood cells (neutrophils). (extremely rare)

• Aplastic anemia - marrow doesn't make enough new blood cells.

(extremely rare)

03/21/13 29GKM/BIO319:Antibiotics/Sem2/2013

Page 30: Antibiotics Lecture 04

Toxicity/Contraindications of Sulfonamides - immune

• Hypersensitivity reactions (common to uncommon)– Skin and mucous membrane

manifestations (rashes)– Serum sickness - type III hypersensitivity

reaction that results from the injection of heterologous or foreign protein or serum

– Focal or diffuse necrosis of the liver (rare)

03/21/13 30GKM/BIO319:Antibiotics/Sem2/2013

Page 31: Antibiotics Lecture 04

Toxic Epidermal Necrolysis (TEN)

03/21/13 31GKM/BIO319:Antibiotics/Sem2/2013

Page 32: Antibiotics Lecture 04

Toxicity/Contraindications of Sulfonamides - miscellaneous

• Nausea, anorexia, vomiting (common)

• Kernicterus; damage caused by excessive jaundice– Displacement of bilirubin from

plasma albumin to brain resulting in encephalopathy(disease of the brain)

– Never give sulfa drugs to a pregnant or lactating woman

• Potentiation of oral coagulants, sulfonylurea hypoglycemic drugs, and hydrantoin anticonvulsants

Bilirubin deposits in neonatal Bilirubin deposits in neonatal brainbrain

03/21/13 32GKM/BIO319:Antibiotics/Sem2/2013

Page 33: Antibiotics Lecture 04

INJURY TO THE PLASMA MEMBRANE - Brief

• All cells are bound by a cell membrane. • And although the membranes of all cells are quite

similar, those of bacteria and fungi differ from eukaryotic cells.

• These slight differences allow for selective action of some antimicrobial agents.

• Certain antibiotics, like polymyxins, act as detergents to dissolve bacterial cell membranes by binding to phospholipids present in the membranes.

03/21/13 GKM/BIO319:Antibiotics/Sem2/2013 33

Page 34: Antibiotics Lecture 04

Antibiotic Resistance• A variety of mutations can lead to antibiotic resistance

• Mechanisms of antibiotic resistance

1. Enzymatic destruction of drug

2. Prevention of penetration of drug

3. Alteration of drug's target site

4. Rapid ejection of the drug

• Resistance genes are often on plasmids or transposons that can be transferred between bacteria.

03/21/13 34GKM/BIO319:Antibiotics/Sem2/2013

Page 35: Antibiotics Lecture 04

Transmission of drug resistance

• Transmission of drug resistance – Bacterial plasmids – Transposons – Bacteriophages

03/21/13 GKM/BIO319:Antibiotics/Sem2/2013 35

Page 36: Antibiotics Lecture 04

Resistance to Antibiotics

03/21/13 36GKM/BIO319:Antibiotics/Sem2/2013

Page 37: Antibiotics Lecture 04

Role of “misuse”

• Misuse of antibiotics selects for resistance mutants.

• Misuse includes;– Using outdated or weakened antibiotics– Using antibiotics for the common cold and other

inappropriate conditions– Using antibiotics in animal feed– Failing complete the prescribed regimen– Using someone else's leftover prescription

03/21/13 37GKM/BIO319:Antibiotics/Sem2/2013

Page 38: Antibiotics Lecture 04

Microbe Library

American Society for Microbiology

www.microbelibrary.org

03/21/13 38GKM/BIO319:Antibiotics/Sem2/2013

Page 39: Antibiotics Lecture 04

Antimicrobial Drug ResistanceMechanisms

• Altered permeability– Altered efflux

• tetracycline

Microbe Library

American Society for Microbiology

www.microbelibrary.org

03/21/13 39GKM/BIO319:Antibiotics/Sem2/2013

Page 40: Antibiotics Lecture 04

Antimicrobial Drug ResistanceMechanisms

• Inactivation– β-lactamase– Chloramphenicol

acetyl transferase

Microbe Library

American Society for Microbiology

www.microbelibrary.org

03/21/13 40GKM/BIO319:Antibiotics/Sem2/2013

Page 41: Antibiotics Lecture 04

Antimicrobial Drug ResistanceMechanisms

• Altered target site– Penicillin binding proteins

(penicillins)– RNA polymerase (rifampin)– 30S ribosome

(streptomycin)

Microbe Library

American Society for Microbiology

www.microbelibrary.org

03/21/13 41GKM/BIO319:Antibiotics/Sem2/2013

Page 42: Antibiotics Lecture 04

Antimicrobial Drug Resistance Mechanisms

• Replacement of a sensitive pathway– Acquisition of a resistant enzyme

(sulfonamides, trimethoprim)

03/21/13 42GKM/BIO319:Antibiotics/Sem2/2013